1. Anell, A, Norinder, A. Health outcome measures used in cost-effectiveness studies: A review of original articles published between 1986 and 1996. Health Policy. 2000;51:87–99.
2. Anis, AH, Rahman, T, Schechter, MT. Using pharmacoeconomic analysis to make drug insurance coverage decisions. Pharmacoeconomics. 1998;13:119–126.
3. Baladi, JF, Menon, D, Otten, N. Use of economic evaluation guidelines: 2 years' experience in Canada. Health Econ. 1998;7:221–227.
4. Barber, JA, Thompson, SG. Analysis and interpretation of cost data in randomised controlled trials: Review of published studies. BMJ. 1998;317:1195–1200.
5. Briggs, AH. Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol. 2004;16:551–561.
6. Cameron, AC, Trivedi, PK. Regression analysis of count data. Cambridge: Cambridge University Press; 1998.
7. Canadian Agency for Drug and Technologies in Health (CADTH). Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: CADTH; 2006.
8. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. 1st edition; 1994.
9. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd edition; 1997.
10. Claxton, K, Sculpher, M, McCabe, C et al. , Probabilistic sensitivity analysis for NICE technology assessment: Not an optional extra. Health Econ. 2005;14:339–347.
11. Cornago, D, Li Bassi, L, De Compadri, P, Garattini, L. Pharmacoeconomic studies in Italy: A critical review of the literature. Eur J Health Econ. 2007;8:89–95.
12. Dalziel, K, Segal, L, Mortimer, D. Review of Australian health economic evaluation – 245 interventions: What can we say about cost effectiveness? Cost Eff Resour Alloc. 2008;6:9.
13. Doshi, JA, Glick, HA, Polsky, D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health. 2006;9:334–340.
14. Fenwick, E, Claxton, K, Sculpher, M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779–787.
15. Garattini, L, De Compadri, P, Clemente, R, Cornago, D. Economic evaluations in Italy: A review of the literature. Int J Technol Assess Health Care. 2003;19:685–691.
16. Garcia-Altes, A. Twenty years of health care economic analysis in Spain: Are we doing well? Health Econ. 2001;10:715–729.
17. Graves, N, Walker, D, Raine, R et al. , Cost data for individual patients included in clinical studies: No amount of statistical analysis can compensate for inadequate costing methods. Health Econ. 2002;11:735–739.
18. Greene, WH. Econometric analysis. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2000.
19. Hutchinson, MK, Holtman, MC. Analysis of count data using poisson regression. Res Nurs Health. 2005;28:408–418.
20. Lee, KS, Brouwer, WBF, Lee, SI, Koo, HW. Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics. 2005;23:709–721.
21. Machado, M, Iskedjian, M, Einarson, TR. Quality assessment of published health economic analyses from South America. Ann Pharmacother. 2006;40:943–949.
22. Nixon, J, Stoykova, B, Glanville, J et al. , The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology. Int J Technol Assess Health Care. 2000;16:731–742.
23. Ramsey, S, Willke, R, Briggs, A et al. , Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–533.
24. Salkeld, G, Davey, P, Arnolda, G. A critical review of health-related economic evaluations in Australia: Implications for health policy. Health Policy. 1995;31:111–125.
25. Schwappach, DL, Boluarte, TA. HEE-GER: A systematic review of German economic evaluations of health care published 1990–2004. BMC Health Serv Res. 2007;7:7.
26. Tarride, JE, McCarron, CE, Lim, M et al. , Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand? Int J Technol Assess Health Care. 2008;24:437–444.